Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-18 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-09 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-06 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |